| Authors: |
Khan K; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Athauda A; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Aitken K; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Cunningham D; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Watkins D; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Starling N; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Cook GJ; Department of Nuclear Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Kalaitzaki E; Department of Statistics, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Chau I; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom., Rao S; GI and Lymphoma Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom sheela.rao@rmh.nhs.uk. |